Shauna Hegarty
Royal Victoria Hospital(GB)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Peptidase Inhibition and Analysis, Melanoma and MAPK Pathways, Cancer Cells and Metastasis, Immunotherapy and Immune Responses
Most-Cited Works
- → P-Rex1 is required for efficient melanoblast migration and melanoma metastasis(2011)178 cited
- → Increased claudin‐4 expression is associated with poor prognosis and high tumour grade in breast cancer(2008)150 cited
- → CENP‐F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer(2007)129 cited
- → Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo(2017)113 cited
- → Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis(2009)108 cited
- → Cathepsin S from both tumor and tumor‐associated cells promote cancer growth and neovascularization(2013)98 cited
- → The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study(2011)71 cited
- → Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis(2010)60 cited
- → The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL(2011)37 cited
- → Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis(2010)22 cited